Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT06892002
Brief Title:
Description of Patients With Type 1 Diabetes Treated With Teplizumab
Official Title:
A Real-World Observational Study Characterizing Patients With Type 1 Diabetes Treated With Teplizumab
Acronym:
TEPLI-REAL
Study:
NCT06892002
Protocol Section:
NCT06892002